Cognizant boosts Medidata alliance for clinical trial tech
TEANECK, N.J. - Cognizant Technology Solutions Corporation (NASDAQ:CTSH), a prominent player in the IT Services industry with ...
Cognizant price target raised to $80 from $75 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Cognizant (CTSH) to $80 from $75 and keeps an Equal Weight rating on the shares while ...
Outlook Business5d
Infosys vs Cognizant: Why IT Services Majors Are Dragging Out Fight Over Trade Secrets
Cognizant sued Infosys, accusing it of stealing secrets related to its US subsidiary TriZetto's healthcare insurance software ...
Cognizant Taps Nerve With Neuro AI Multi-Agent Accelerator
A new AI development framework and services are said to fast track multi-agent adoption by enabling interoperability and scalability to transform business processes.
Davos 2025: About 10,000 more ex-employees want to rejoin Cognizant, says CEO Ravi Kumar S
On the counterclaim filed by Infosys in the TriZetto trade secrets case, Kumar says he is protecting the intellectual ...
CRN8d
Cognizant CTO Of AI: Here’s How Consumer AI Trends Will Impact B2B Companies
Cognizant released a study on young consumers’ increased use of AI, and discussed how that will impact designing AI systems ...
Josh Brown's best stocks list: IBM, Gartner, Cognizant Tech, Accenture, Cloudflare and GoDaddy
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to reveal his favorite stocks in the market.
Cognizant-L&T bribery case: Will US govt’s ‘essential witness’ be able to testify?
The testimony of Srimanikandan Ramamoorthy, dubbed an ‘essential witness’ by the US Department of Justice, is critical, ...